302 related articles for article (PubMed ID: 17136956)
1. A two-stage logistic model based on the measurement of pro-inflammatory cytokines in bronchial secretions for assessing bacterial, viral, and non-infectious origin of COPD exacerbations.
Dal Negro RW; Micheletto C; Tognella S; Visconti M; Guerriero M; Sandri MF
COPD; 2005 Mar; 2(1):7-16. PubMed ID: 17136956
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory profile of new bacterial strain exacerbations of chronic obstructive pulmonary disease.
Sethi S; Wrona C; Eschberger K; Lobbins P; Cai X; Murphy TF
Am J Respir Crit Care Med; 2008 Mar; 177(5):491-7. PubMed ID: 18079493
[TBL] [Abstract][Full Text] [Related]
3. Effect of interactions between lower airway bacterial and rhinoviral infection in exacerbations of COPD.
Wilkinson TMA; Hurst JR; Perera WR; Wilks M; Donaldson GC; Wedzicha JA
Chest; 2006 Feb; 129(2):317-324. PubMed ID: 16478847
[TBL] [Abstract][Full Text] [Related]
4. Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations.
Papi A; Bellettato CM; Braccioni F; Romagnoli M; Casolari P; Caramori G; Fabbri LM; Johnston SL
Am J Respir Crit Care Med; 2006 May; 173(10):1114-21. PubMed ID: 16484677
[TBL] [Abstract][Full Text] [Related]
5. Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers.
Bafadhel M; McKenna S; Terry S; Mistry V; Reid C; Haldar P; McCormick M; Haldar K; Kebadze T; Duvoix A; Lindblad K; Patel H; Rugman P; Dodson P; Jenkins M; Saunders M; Newbold P; Green RH; Venge P; Lomas DA; Barer MR; Johnston SL; Pavord ID; Brightling CE
Am J Respir Crit Care Med; 2011 Sep; 184(6):662-71. PubMed ID: 21680942
[TBL] [Abstract][Full Text] [Related]
6. Exacerbations of chronic obstructive pulmonary disease.
Wedzicha JA; Donaldson GC
Respir Care; 2003 Dec; 48(12):1204-13; discussion 1213-5. PubMed ID: 14651761
[TBL] [Abstract][Full Text] [Related]
7. Tobramycin Nebulizer Solution in severe COPD patients colonized with Pseudomonas aeruginosa: effects on bronchial inflammation.
Dal Negro R; Micheletto C; Tognella S; Visconti M; Turati C
Adv Ther; 2008 Oct; 25(10):1019-30. PubMed ID: 18821068
[TBL] [Abstract][Full Text] [Related]
8. [Etiology and biomarkers of systemic inflammation in mild to moderate COPD exacerbations].
Saldías PF; Díaz PO; Dreyse DJ; Gaggero BA; Sandoval AC; Lisboa BC
Rev Med Chil; 2012 Jan; 140(1):10-8. PubMed ID: 22552550
[TBL] [Abstract][Full Text] [Related]
9. Procalcitonin and C-reactive protein cannot differentiate bacterial or viral infection in COPD exacerbation requiring emergency department visits.
Chang CH; Tsao KC; Hu HC; Huang CC; Kao KC; Chen NH; Yang CT; Tsai YH; Hsieh MJ
Int J Chron Obstruct Pulmon Dis; 2015; 10():767-74. PubMed ID: 25926728
[TBL] [Abstract][Full Text] [Related]
10. Serum inflammatory biomarkers and clinical outcomes of COPD exacerbation caused by different pathogens.
Kawamatawong T; Apiwattanaporn A; Siricharoonwong W
Int J Chron Obstruct Pulmon Dis; 2017; 12():1625-1630. PubMed ID: 28615935
[TBL] [Abstract][Full Text] [Related]
11. Microbiologic determinants of exacerbation in chronic obstructive pulmonary disease.
Rosell A; Monsó E; Soler N; Torres F; Angrill J; Riise G; Zalacaín R; Morera J; Torres A
Arch Intern Med; 2005 Apr; 165(8):891-7. PubMed ID: 15851640
[TBL] [Abstract][Full Text] [Related]
12. Change in inflammation in out-patient COPD patients from stable phase to a subsequent exacerbation.
Bathoorn E; Liesker JJ; Postma DS; Koëter GH; van der Toorn M; van der Heide S; Ross HA; van Oosterhout AJ; Kerstjens HA
Int J Chron Obstruct Pulmon Dis; 2009; 4():101-9. PubMed ID: 19436694
[TBL] [Abstract][Full Text] [Related]
13. Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease.
Aaron SD; Angel JB; Lunau M; Wright K; Fex C; Le Saux N; Dales RE
Am J Respir Crit Care Med; 2001 Feb; 163(2):349-55. PubMed ID: 11179105
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory response in acute viral exacerbations of COPD.
Rohde G; Borg I; Wiethege A; Kauth M; Jerzinowski S; An Duong Dinh T; Bauer TT; Bufe A; Schultze-Werninghaus G
Infection; 2008 Oct; 36(5):427-33. PubMed ID: 18795228
[TBL] [Abstract][Full Text] [Related]
15. Exacerbations of chronic obstructive pulmonary disease: when are bacteria important?
Miravitlles M
Eur Respir J Suppl; 2002 Jul; 36():9s-19s. PubMed ID: 12168752
[TBL] [Abstract][Full Text] [Related]
16. C-reactive protein in outpatients with acute exacerbation of COPD: its relationship with microbial etiology and severity.
Gallego M; Pomares X; Capilla S; Marcos MA; Suárez D; Monsó E; Montón C
Int J Chron Obstruct Pulmon Dis; 2016; 11():2633-2640. PubMed ID: 27799762
[TBL] [Abstract][Full Text] [Related]
17. [The role of respiratory infection in exacerbation of chronic obstructive pulmonary disease].
Dacydchenko SV; Bova AA
Klin Med (Mosk); 2007; 85(5):10-5. PubMed ID: 17665597
[TBL] [Abstract][Full Text] [Related]
18. Association between cytokines in induced sputum and severity of chronic obstructive pulmonary disease.
Hacievliyagil SS; Gunen H; Mutlu LC; Karabulut AB; Temel I
Respir Med; 2006 May; 100(5):846-54. PubMed ID: 16214322
[TBL] [Abstract][Full Text] [Related]
19. Relationship between the GOLD combined COPD assessment staging system and bacterial isolation.
Aydemir Y; Aydemir Ö; Kalem F
Int J Chron Obstruct Pulmon Dis; 2014; 9():1045-51. PubMed ID: 25298733
[TBL] [Abstract][Full Text] [Related]
20. Respiratory infectious phenotypes in acute exacerbation of COPD: an aid to length of stay and COPD Assessment Test.
Dai MY; Qiao JP; Xu YH; Fei GH
Int J Chron Obstruct Pulmon Dis; 2015; 10():2257-63. PubMed ID: 26527871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]